Perrigo Returns to Profit, Despite Revenue Decline

Perrigo reported fiscal 2026 Q2 earnings on Aug 06th, 2026. The company delivered an EPS surprise of +61.29% against consensus estimates, significantly beating Wall Street expectations. Revenue also exceeded the Zacks Consensus Estimate by 1.89%. While full-year guidance was provided in-line with current performance trends, the results demonstrate a strong operational turnaround and robust profitability recovery compared to the prior year's losses.

Revenue

The total revenue of Perrigo decreased by 3.2% to $1.02 billion in 2026 Q2, down from $1.06 billion in 2025 Q2. In terms of segment performance, Self Care contributed $576.60 million, while Specialty Care generated $226.60 million. The Infant Formula segment accounted for $100.90 million, and the All Other category added $118.60 million, bringing the Total Consolidated net sales to $1.02 billion.

Earnings/Net Income

Perrigo returned to profitability with EPS of $0.54 in 2026 Q2, reversing from a loss of $0.06 per share in 2025 Q2 (1000.0% positive change). Meanwhile, the company achieved a remarkable turnaround with net income of $74.50 million in 2026 Q2, representing a 986.9% positive swing from the net loss of $-8.40 million in 2025 Q2. This substantial improvement indicates a highly effective cost management strategy and strong margin expansion.

Price Action

The stock price of Perrigo has climbed 5.15% during the latest trading day, has surged 27.23% during the most recent full trading week, and has surged 19.66% month-to-date.

Post-Earnings Price Action Review

Following the earnings release, Perrigo shares exhibited significant positive momentum, reflecting investor confidence in the company's turnaround story. The stock climbed 5.15% on the day of the report and surged 27.23% over the subsequent full trading week. This strong immediate reaction was further supported by a 19.66% month-to-date gain, indicating that the market viewed the EPS beat and net income recovery as pivotal developments. Despite the revenue decline, the focus on high-margin products and operational efficiency appears to have resonated well with investors, driving substantial short-term price appreciation.

CEO Commentary

Perrigo’s Chief Executive Officer highlighted the company’s strong operational execution in the second quarter of 2026, driving robust financial results. The leadership team emphasized that growth was primarily fueled by strategic investments in high-margin branded products and international expansion, which successfully offset temporary supply chain headwinds in certain regions. Strategic priorities remain firmly focused on accelerating innovation in self-care and leveraging digital health platforms to enhance customer engagement. The CEO maintained a cautiously optimistic tone, noting that while market dynamics remain competitive, the company’s diversified portfolio and disciplined cost management position Perrigo well for sustained long-term value creation. The executive expressed confidence in the organization’s ability to navigate macroeconomic uncertainties through agile decision-making and continued focus on operational excellence.

Guidance

The company provided specific quantitative targets for the remainder of 2026, citing an expected EPS of $0.5400 and total revenue of $1,022,800,000.00, which aligns with reported net income of $74,500,000.00. Qualitative expectations emphasize maintaining double-digit organic growth in key segments while optimizing capital allocation toward high-return initiatives. Management indicated a commitment to disciplined CAPEX spending to support infrastructure upgrades and digital transformation without compromising liquidity. Forward-looking statements underscored a focus on margin expansion through operational efficiencies and strategic pricing actions. The guidance reflects a balanced approach to growth and profitability, acknowledging potential volatility in input costs while projecting resilience through diversified revenue streams and strong cash flow generation capabilities.

Additional News

Perrigo shares have experienced notable volatility in recent weeks, with the stock losing about 22.6% since the beginning of the year versus the S&P 500's gain of 13%. Despite this underperformance, the company currently holds a Zacks Rank #3 (Hold), suggesting it could perform in line with the broader market in the near term. Investors are closely monitoring the sustainability of the stock's immediate price movement, which will largely depend on management's commentary during the earnings call and future earnings expectations. While no major M&A or C-level changes were reported in the immediate vicinity, the focus remains on the company's ability to maintain its turnaround trajectory and deliver consistent value amidst competitive market dynamics.